CYTK: Mizuho Raises Target
Mizuho maintains outperform rating on Cytokinetics and raises price target to $118
Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $118
Mizuho maintains outperform rating on Cytokinetics and raises price target to $118
Mizuho Maintains Outperform on Cytokinetics, Raises Price Target to $118